Bharat Biotech
-
Top News
Covaxin Gets Approval For Restricted Emergency Use In Children Aged 6-12 Years
Mumbai: Drugs Controller General of India (DCGI) has granted restricted emergency use authorisation to Bharat Biotech’s Covaxin for children between…
Read More » -
Top News
Bharat Biotech’s Intranasal COVID-19 Vaccine Approved For Booster Dose Trials
Mumbai: The Drugs Controller General of India on Friday permitted Bharat Biotech to conduct trials for its intranasal COVID-19 booster…
Read More » -
WORLD
COVID-19: India Supplies 5 Lakh More Covaxin Doses To Afghanistan
Mumbai: Bharat Biotech on Monday informed that India has supplied another batch of humanitarian aid to Afghanistan, which includes 5,00,000…
Read More » -
Top News
UK To Add Covaxin To Approved List Of COVID-19 Vaccines From November 22
Mumbai: The UK government will recognise vaccines on the World Health Organization’s Emergency Use Listing from November 22, as a…
Read More » -
Top News
Covaxin Gets WHO Approval For Emergency Use Listing
Mumbai: The World Health Organization (WHO) has approved the Emergency Use List (EUL) for Covaxin, a COVID-19 vaccine from Hyderabad-based…
Read More » -
Top News
Australia Recognises India’s Covaxin For Travel Purposes
Mumbai: Australia on Monday determined that India’s Covaxin vaccine manufactured by Hyderabad-based Bharat Biotech and China’s BBIBP-CorV vaccine would be…
Read More » -
INDIA
WHO To Decide On Bharat Biotech’s Covaxin Emergence Use Listing In October
Mumbai: The World Health Organization (WHO) informed that the final decision on Bharat Biotech’s submission for its Covaxin Covid-19 vaccine…
Read More » -
Top News
Covaxin Effectively Neutralises Alpha And Delta Variants Of COVID-19: US Health Body
Mumbai: COVID-19 vaccine Covaxin, produced by Bharat Biotech, effectively neutralizes both Alpha and Delta strains of coronavirus, according to the…
Read More » -
Top News
COVAXIN At ₹150 Per Dose To Centre Not Sustainable In Long Run: Bharat Biotech
Mumbai: Bharat Biotech on Tuesday said, “The supply price of COVAXIN to the Centre at ₹150 per dose, is non-competitive…
Read More » -
Top News
Single-Shot Covishield & Mixing Doses Of 2 Vaccines Not Approved Yet: Govt
Mumbai: There’s no change in the schedule of Covishield doses and both doses will have to be administered with a…
Read More »